GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Oxford University Press (OUP)  (3)
  • Ruiz-Veguilla, Miguel  (3)
  • 1
    In: Schizophrenia Bulletin, Oxford University Press (OUP), Vol. 46, No. Supplement_1 ( 2020-05-18), p. S171-S172
    Abstract: The category ‘brief psychotic disorder’ (BPD) is defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM) as a short-lived psychotic condition in which delusions, hallucinations, disorganised speech or grossly disorganised or catatonic behaviour are present for at least 1 day but less than 1 month. BPD is a relatively uncommon disease accounting for 2–7% of first-episode psychoses (FEP) and it has been poorly investigated in comparison with other psychotic disorders, probably due to its low prevalence and associated good prognosis. However, FEP patients with BPD have low diagnostic stability at follow-up and a high transition rate (around 55%) to long-lasting psychotic disorders, mainly to schizophrenia. This study explored the proportion of diagnostic transition to schizophrenia after 3 years in a cohort of FEP patients with BPD, to determine whether there were early predictive factors for such transition in this BPD population. Methods A 36-month prospective observational study of patients with first-episode BPD was conducted. The sample included subjects aged 18–60 from the intervention programme of first-episode psychosis non-affective psychosis (PAFIP) of the University Hospital Marques de Valdecilla (Spain). BPD diagnoses were confirmed using the Structured Clinical Interview for DSM-IV (SCID-I) at 6 months following admission into the PAFIP programme. Sociodemographic, premorbid and baseline clinical variables were collected and patients were followed over 3 years while they received treatment in the PAFIP programme. A DSM-IV diagnostic reassessment was performed on those patients who completed the follow-up and subjects were classified according to whether or not they had developed schizophrenia after 3 years. Univariate screening was performed to determine variables eligible for the predictive model, and factors that reached statistical or marginal significance (p ≤ 0.1) were selected for multivariate logistic regression analysis. Significant statistical level was set at 0.05. All statistical evaluation was performed using MedCalc Statistical Software (version 19.0.7). Results Of the 569 patients enrolled in the PAFIP programme between 2001 and 2018, 59 met the criteria for BPD. Of those, 40 (67.8%) completed the 36-month follow-up and 16 (40%) maintained their initial BPD diagnosis. Among the patients who developed other mental disorders by the end of the study period (60%; n = 24), the proportion of transition to schizophrenia was 62.5% (n = 15). Being younger at psychosis onset, living alone, a poor premorbid adjustment, acute onset of psychotic symptomatology, and higher severity of hallucinatory behaviour were variables that showed univariate associations with subsequent development of schizophrenia. A multivariate logistic regression model revealed that transition to schizophrenia was independently significantly associated with younger age at psychosis onset (OR = 0.83, 95% CI 0.69–0.99; p = 0.048), living alone (OR = 14.3, 95% CI 1.09–186.77; p = 0.042) and greater hallucinatory activity (OR = 1.81, 95% CI 1.07–3.07; p = 0.028). Discussion Our main findings were that 37.5% of patients who presented an initial BPD diagnosis developed schizophrenia in the following 36 months. Being younger at psychosis onset, living alone and experiencing greater hallucinatory activity at baseline were independent predictors of diagnostic transition to schizophrenia in this BPD population. Individuals with BPD presenting these risk factors should therefore be targeted for intensive interventions similar to those performed on patients with first-episode schizophrenia.
    Type of Medium: Online Resource
    ISSN: 0586-7614 , 1745-1701
    RVK:
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2020
    detail.hit.zdb_id: 2180196-4
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Schizophrenia Bulletin, Oxford University Press (OUP), Vol. 46, No. Supplement_1 ( 2020-05-18), p. S72-S73
    Abstract: The concept ‘non-affective acute remitting psychosis’ (NARP) embraces a broad set of non-affective psychotic conditions characterised by acute onset (i.e. the change from a non-psychotic to a clearly psychotic state occurred in a period of 2 weeks or less) and brief duration (less than 6 months from onset with full recovery). The prevalence of NARP ranges 5–9% of all first-episode psychosis (FEP) and, due to its limited duration and complete remission, it has generally good prognosis. However, research surrounding predictive indicators of NARP remains scarce. This study examined the clinical and sociodemographic characteristics of NARP patients, to determine whether there are early predictors that could differentiate this disorder from schizophrenia. Methods This research was part of a larger epidemiological 3-year longitudinal study of first-episode non-affective psychosis (PAFIP) conducted at the University Hospital Marques de Valdecilla (Spain). The sample included all patients aged 18–60 enrolled in the PAFIP programme who fullfilled NARP criteria at the end of the study period and their baseline clinical and sociodemographic characteristics were compared with those of patients with acute short-lived psychosis at admission who developed schizophrenia during follow-up. Univariate comparisons between groups were performed using Student’s t-test, Mann-Whitney’s U-test and the Chi-square test, according to distribution and variable type. Multivariate logistic regression analysis was conducted to determine the potential independent effect of each significant or marginally significant (p ≤ 0.1) variable from the univariate analysis. Statistical significance was set as p ≤ 0.05. All statistical procedures were performed using MedCalc Statistical Software (version 19.0.7). Results Of the 391 patients enrolled in the PAFIP programme between 2001 and 2018 who completed the follow-up, 31 met the criteria for NARP at the end of the study period. Mean age was 31.28 years (SD ± 9.44) and gender distribution was slightly higher for females (54.8%; n = 17). According to DSM criteria, NARP patients were classified thus: schizophreniform disorder 48.4% (n = 15), brief psychotic disorder 35.5% (n = 11) and psychotic disorder not otherwise specified 16.1% (n = 5). Univariate comparisons yielded significant differences between NARP patients and those with schizophrenia in terms of negative and activation/excitement symptomatology and in levels of insight, psychosocial functioning and premorbid adjustment. Multivariate logistic regression analysis revealed that fewer negative symptoms at admission (i.e. lower scores on Brief Psychiatric Rating Scale [BPRS] negative symptom subscale; OR = 0.75, 95% CI 0.59–0.95; p = 0.017) and better premorbid adjustment (i.e. lower scores on Cannon-Spoor’s Premorbid Adjustment Scale [PAS]; OR = 0.62, 95% CI 0.41–0.95; p = 0.011) significantly predicted the presence of NARP. Moreover, better insight into having a psychotic disorder (i.e. lower scores on Scale to Assess Unawareness of Mental Disease [SUMD] ) marginally predicted NARP diagnosis (OR = 0.81, 95% CI 0.65–1.01; p = 0.056). Discussion Patients who met the NARP criteria accounted for 7.9% of FEP. Better premorbid adjustment, greater awareness of mental disorder and lower negative symptomatology at admission were independent prognostic factors that differentiated NARP from schizophrenia in FEP patients with acute and short-lived psychosis. Our findings would enable early identification of NARP patients and could therefore be of value in developing more specific interventions in this population.
    Type of Medium: Online Resource
    ISSN: 0586-7614 , 1745-1701
    RVK:
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2020
    detail.hit.zdb_id: 2180196-4
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: International Journal of Neuropsychopharmacology, Oxford University Press (OUP), Vol. 25, No. 11 ( 2022-11-17), p. 900-911
    Abstract: Antipsychotic choice for the acute phase of a first episode of psychosis (FEP) is of the utmost importance since it may influence long-term outcome. However, head-to-head comparisons between second-generation antipsychotics remain scarce. The aim of this study was to compare the effectiveness in the short term of aripiprazole and risperidone after FEP outbreak. Methods From February 2011 to October 2018, a prospective, randomized, open-label study was undertaken. Two hundred-sixty-six first-episode drug-naïve patients were randomly assigned to aripiprazole (n = 136) or risperidone (n = 130) and followed-up for 12 weeks. The primary effectiveness measure was all-cause treatment discontinuation. In addition, an analysis based on intention-to-treat principle was conducted to assess clinical efficacy. Results The overall dropout rate at 12 weeks was small (6.39%). Effectiveness measures were similar between treatment arms as treatment discontinuation rates (χ 2 = 0,409; P = .522), and mean time to all-cause discontinuation (log rank χ 2 = −1.009; P = .316) showed no statistically significant differences. Despite no statistically significant differences between groups regarding clinical efficacy, aripiprazole required higher chlorpromazine equivalent dosage (χ 2 = 2.160; P = .032) and extended mean time (W = 8183.5; P = .008) to reach clinical response. Sex-related adverse events and rigidity were more frequent in the risperidone group, whereas sialorrhea was on the aripiprazole group. Conclusions No differences regarding effectiveness were found between aripiprazole and risperidone for the short-phase treatment of FEP. Despite the importance of efficacy during this phase, differences in side effect profiles and patient’s preferences are essential factors that may lead clinical decisions for these patients. Clinicaltrials.gov NCT02532491. Effectiveness of Second-Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up (PAFIP3_1Y).
    Type of Medium: Online Resource
    ISSN: 1461-1457 , 1469-5111
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2022
    detail.hit.zdb_id: 1501053-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...